These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6773173)

  • 1. Inactivation of human Factor VIII by granulocyte proteases.
    Váradi K; Marossy K; Asbóth G; Elödi P; Elödi S
    Thromb Haemost; 1980 Feb; 43(1):45-8. PubMed ID: 6773173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of neutral proteases from human leukocytes on structure and biological properties of human factor VIII.
    Kopeć M; Bykowska K; Lopaciuk S; Jelenska M; Kaczanowska J; Sopata I; Wojtecka E
    Thromb Haemost; 1980 Jul; 43(3):211-7. PubMed ID: 6256922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bence Jones proteins and light chains of immunoglobulins. XIII. Effect of elastase-like and chymotrypsin-like neutral proteases derived from human granulocytes on Bence Jones proteins.
    Solomon A; Schmidt W; Havemann K
    J Immunol; 1976 Sep; 117(3):1010-4. PubMed ID: 60445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of neutral proteases from blood leukocytes on human platelets.
    Bykowska K; Kaczanowska J; Karpowicz M; Stachurska J; Kopeć M
    Thromb Haemost; 1983 Dec; 50(4):768-72. PubMed ID: 6320486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of granulocyte proteases on human coagulation factors IX and X. The protective effect of calcium.
    Kárpáti J; Váradi K; Elödi S
    Hoppe Seylers Z Physiol Chem; 1982 May; 363(5):521-5. PubMed ID: 7047353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factor VIII complex activities in acute leukemia].
    Pniejnia-Olszyński W; Lopaciuk S
    Acta Haematol Pol; 1980; 11(4):239-47. PubMed ID: 6794320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic cleavage of human IgG molecules by neutral proteases of polymorphonuclear leukocytes.
    Solomon A; Gramse M; Havemann K
    Eur J Immunol; 1978 Nov; 8(11):782-5. PubMed ID: 102513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation.
    Hoyer LW; Trabold NC
    J Lab Clin Med; 1981 Jan; 97(1):50-64. PubMed ID: 6778941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VIII and human platelet aggregation. IV. Effect of proteolytic enzymes on platelet aggregation by factor VIII.
    Vermylen J; Bottecchia D
    Br J Haematol; 1976 Oct; 34(2):331-40. PubMed ID: 135576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot.
    Bagoly Z; Haramura G; Muszbek L
    Thromb Haemost; 2007 Aug; 98(2):359-67. PubMed ID: 17721618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
    Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
    Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D
    Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased resistance of factor IXa-factor VIII complex against inactivation by granulocyte proteases.
    Váradi K; Elõdi S
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):571-8. PubMed ID: 6777896
    [No Abstract]   [Full Text] [Related]  

  • 15. [Direct proteolysis of coagulation factors through granulocyte enzymes as a possible mechanism of blood coagulation disorders in acute leukemia and septicemia].
    Egbring R; Schmidt W; Havemann K
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1629-32. PubMed ID: 1030064
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of retention time on degradation of pancreatic enzymes by human colonic bacteria grown in a 3-stage continuous culture system.
    Macfarlane GT; Cummings JH; Macfarlane S; Gibson GR
    J Appl Bacteriol; 1989 Nov; 67(5):520-7. PubMed ID: 2480341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
    Gibson TL; Cohen P
    Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabbit antibodies against the procoagulant activity (VIII:C) of human factor VIII. Some theoretical and practical considerations on the human factor VIII molecule using heterologous antibodies.
    Tran TH; Marbet GA; Duckert F
    Thromb Haemost; 1981 Dec; 46(4):699-705. PubMed ID: 6800051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid method for purification of human granulocyte cationic neutral proteases: purification and characterization of human granulocyte chymotrypsin-like enzyme.
    Feinstein G; Janoff A
    Biochim Biophys Acta; 1975 Oct; 403(2):477-92. PubMed ID: 1081003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of factor VIII/von Willebrand factor to intranasal DDAVP in healthy subjects and mild haemophiliacs (with observations in patients with combined deficiency of factors V and VIII).
    Garcia VV; Silva IA; Borrasca AL
    Thromb Haemost; 1982 Aug; 48(1):91-3. PubMed ID: 6813999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.